Acadia Pharmaceuticals Ratios (2010-2026) | ACAD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	97.81%	97.20%	91.78%	97.45%	98.02%	98.37%	98.23%	98.59%	95.49%	93.09%	92.26%	88.85%	92.47%	92.47%	91.60%	91.65%	92.16%	92.23%	90.77%	90.75%
EBT Margin (Quarter)	-37.67%	-11.24%	-32.81%	-97.49%	-24.95%	-20.20%	-29.92%	-37.94%	3.84%	-24.61%	17.17%	10.20%	15.37%	15.50%	62.05%	11.38%	15.19%	16.00%	9.26%	1.49%
EBIT Margin (Quarter)	-37.93%	-11.63%	69.29%	-97.88%	-25.01%	-23.61%	-33.75%	-45.23%	1.84%	-27.29%	15.12%	7.39%	12.58%	12.64%	59.13%	7.90%	12.24%	12.83%	-20.46%	-1.72%
EBITDA Margin (Quarter)	-37.93%	-11.63%	69.29%	-97.88%	-25.01%	-23.61%	-33.75%	-45.23%	1.84%	-27.29%	15.12%	7.39%	12.58%	12.64%	59.13%	7.90%	12.24%	12.83%	-20.46%	-1.72%
Operating Margin (Quarter)	-37.93%	-11.63%	69.29%	-97.88%	-25.01%	-23.61%	-33.75%	-45.23%	1.84%	-27.29%	15.12%	7.39%	12.58%	12.64%	59.13%	7.90%	12.24%	12.83%	-20.46%	-1.72%
Net Margin (Quarter)	-38.08%	-10.98%	-32.96%	-97.91%	-25.24%	-20.78%	-30.53%	-36.32%	0.67%	-30.79%	19.82%	8.04%	13.80%	13.09%	55.37%	7.77%	10.08%	25.76%	96.33%	1.36%
FCF Margin (Quarter)	-22.02%	-12.97%	-17.68%	-66.10%	-9.75%	-0.56%	-17.48%	-15.14%	4.96%	-27.85%	36.96%	14.13%	10.34%	25.23%	15.38%	8.32%	24.06%	26.52%	-18.57%	10.73%
Efficiency
Inventory Average (Quarter)	10.55M	12.56M	11.11M	7.45M	6.67M	6.09M	6.24M	6.37M	7.65M	14.98M	28.29M	48.88M	66.73M	66.28M	41.49M	22.45M	24.54M	27.61M	31.88M	33.12M
Assets Average (Quarter)	739.80M	721.05M	708.90M	662.19M	618.51M	607.63M	595.15M	621.56M	649.04M	637.65M	690.75M	802.03M	884.60M	945.48M	1,082.31M	1,160.06M	1,178.96M	1,278.16M	1,447.48M	1,584.71M
Equity Average (Quarter)	573.22M	565.90M	553.92M	492.85M	439.82M	430.27M	413.05M	387.34M	385.03M	378.98M	396.96M	447.90M	490.37M	546.94M	654.99M	749.01M	793.81M	869.83M	1,072.33M	1,237.73M
Invested Capital (Quarter)	564.84M	566.96M	540.89M	444.80M	434.85M	425.69M	400.41M	374.26M	395.79M	362.17M	431.75M	464.04M	516.70M	577.18M	732.79M	765.24M	822.38M	917.27M	1,227.39M	1,248.07M
Asset Utilization Ratio (Quarter)	0.63	0.66	0.68	0.74	0.83	0.84	0.87	0.84	0.85	0.99	1.05	1.01	1.01	0.98	0.88	0.86	0.86	0.82	0.74	0.69
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.78	0.79	0.77	0.71	0.71	0.71	0.68	0.57	0.62	0.57	0.58	0.54	0.57	0.59	0.62	0.68	0.67	0.69	0.78	0.78
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-556.92M	-540.29M	-520.71M	-445.98M	-436.35M	-436.58M	-416.82M	-402.87M	-375.38M	-345.92M	-438.87M	-470.52M	-500.94M	-565.33M	-755.99M	-681.58M	-762.00M	-847.02M	-819.69M	-851.46M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.01%	0.00%
Return on Capital Employed (Quarter)	-5.58%	5.47%	-5.74%	-15.01%	-14.25%	-17.70%	-47.62%	-41.32%	-27.65%	-36.07%	-16.81%	-0.97%	4.17%	18.66%	33.57%	27.39%	27.90%	26.14%	2.50%	0.42%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Acadia Pharmaceuticals Ratios (2010-2026) | ACAD

Research Tools

Developers

Acadia Pharmaceuticals Ratios (2010-2026) | ACAD

Create an account

Sign In

Reset Password